相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
NAFLD and diabetes mellitus
Herbert Tilg et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
Pedro M. Rodrigues et al.
CELL DEATH & DISEASE (2017)
Current and future pharmacologic treatment of nonalcoholic steatohepatitis
Bubu A. Banini et al.
CURRENT OPINION IN GASTROENTEROLOGY (2017)
Effects of Oral Antidiabetic Drugs on Changes in the Liver-to-Spleen Ratio on Computed Tomography and Inflammatory Biomarkers in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Koichi Yabiku et al.
CLINICAL THERAPEUTICS (2017)
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression
Xavier Loyer et al.
GUT (2016)
Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment
Byung-Hak Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption
Nicolas Calo et al.
GUT (2016)
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Santhosh Satapati et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Performance of Serum microRNAs-122,-192 and-21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis
Philip P. Becker et al.
PLOS ONE (2015)
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
Carlos J. Pirola et al.
GUT (2015)
Systematic review: Preventive and therapeutic applications of metformin in liver disease
Aparna Bhat et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Micro RNAs in the development of non-alcoholic fatty liver disease
Glenn S. Gerhard et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
Zhongquan Zhao et al.
PLOS ONE (2014)
Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes
Annika Nerstedt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Therapeutic modulators of STAT signalling for human diseases
Gabriella Miklossy et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The genetics of NAFLD
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Interplay between microRNAs and the STAT3 signaling pathway in human cancers
Qing Cao et al.
PHYSIOLOGICAL GENOMICS (2013)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
Yuki Kita et al.
PLOS ONE (2012)
Label-free Evaluation of Hepatic Microvesicular Steatosis with Multimodal Coherent Anti-Stokes Raman Scattering Microscopy
Thuc T. Le et al.
PLOS ONE (2012)
Optimization of the HepaRG cell model for drug metabolism and toxicity studies
Sebastien Antherieu et al.
TOXICOLOGY IN VITRO (2012)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors
Arun K. Mankan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Fabio Marra et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy
Thomas Hellerer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)
分享论文
